You searched for Health Technology Assessment (HTA) - Page 9 of 12 - OHE

We found for

News
January 2017

Value and Cancer: Journal of Cancer Policy Special Issue

Routine Funding in the NHS in the UK of Medicines Authorised Between 2011 and 2016 via the European Centralised Procedure

Read more

Antimicrobials Resistance: A Call for Multi-disciplinary Action. How Can HTA Help?

Read more

News
January 2017

New Publication: Assessing Evidence and Access Associated with NICE HTA Decisions Categorised as “Recommended in Line with Clinical Practice”

Ten Years of the NIHR: Achievements and Challenges for the Next Decade

Read more

Additional Elements of Value for Health Technology Assessment Decisions

Read more

News
January 2017

Recently Published: Reports on Policy Options for Formulary Development in Middle-income Countries and A Case Study from Mexico

Age and Utilities: Issues for HTA

Read more

How can HTA meet the needs of health system and government decision makers?

Read more

Transferability of HTA

Read more

HTA and Decision Making in Asia: How can the available resources be used most effectively to deliver high quality HTA that can be used by health system decision makers?

Read more

Gene Therapy: Understanding the Science, Assessing the Evidence, and Paying for Value

Read more

Comparing the UK EQ-5D-3L and the English EQ-5D-5L Value Sets

Read more

Exploring the Assessment and Appraisal of Regenerative Medicines and Cell Therapy Products: Is the NICE Approach Fit for Purpose?

Read more

News
December 2016

Recently Published: MCDA to Elicit Stakeholders’ Preferences: The Case of Obinutuzumab for Rituximab-Refractory Indolent Non-Hodgkin Lymphoma

News
December 2016

New OHE Research Paper: Uncertainty and Risk in HTA Decision Making

00
05
06
07
08
09
10
11
12
13
00